{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-22-000013","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2022-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.009047+00:00","generated_at":"2026-06-27T16:07:21.290274+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Landec Corporation elects Ray Diradoorian to Board as Class 2 director","bullets":["Board expanded to 11 members; Ray Diradoorian elected effective Jan 20, 2022.","Diradoorian appointed to Lifecore Focus Committee.","No material interest in transactions over $120k with the company.","Standard director compensation: $50k annual cash retainer plus $90k RSU award (initial $30k pro-rated)."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-22-000013","json":"https://secwatch.observer/filing/0001005286-22-000013.json","markdown":"https://secwatch.observer/filing/0001005286-22-000013.md","text":"https://secwatch.observer/filing/0001005286-22-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000013/0001005286-22-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000013/lndc-20220120.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:07:21.290274+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7d80c90de8","claim":"Ray Diradoorian was elected as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"On January 20, 2022 the Board of Directors (the “Board”) of Landec Corporation (the “Company”) increased the size of the Board to 11 members and elected Ray Diradoorian to serve as a member of the Board, Class 2 Director and member of the Lifecore Focus Committee.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528622000013/0001005286-22-000013-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}